WHO ICTRP trial
A study investigating whether progesterone supplementation in otherwise…
EUCTR2019-003468-27-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-003468-27-GB |
|---|---|
| Public title | A study investigating whether progesterone supplementation in otherwise unmedicated, natural menstrual cycles can improve live birth rates |
| Scientific title | A Randomised Controlled trial investigating the effects of Progesterone for luteal phase support in Natural Cycles for unexplained infertility - Progesterone in Natural Cycles (PiNC) |
| Primary sponsor | Homerton University Hospital NHS Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Unexplained infertility MedDRA version: 20.1 Level: PT Classification code 10049513 Term: Luteal phase deficiency System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Female diseases of the urinary and… |
| Interventions | Trade Name: Cyclogest Product Name: Cyclogest Pharmaceutical Form: Pessary INN or Proposed INN: Progesterone CAS Number: 57-83-0 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 400- |
| Registration date | Mar 10, 2019 |
| Target size | 200 |
| Secondary IDs | PiNCv.1.1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: